Active ingredientLatrepirdine DiHClCat. No. P-L026-001CAS 97657-92-6Family · Pharmaceutical analytical standards
Latrepirdine
An antihistamine that entered clinical use in Russia in 1983, also known as dimebolin. It was later tested for Alzheimer's disease and Huntington's disease, but the phase III trials, completed between 2010 and 2012, did not confirm its efficacy. This family brings together the active ingredient and other impurities.
Did you know?Its 'second life' began in 2000 with Russian animal studies suggesting a protective effect on brain cells; unlike many older antihistamines, it also has no anticholinergic effects.
Go to the active ingredient →Active ingredientLatrepirdine DiHClCat. No. P-L026-001CAS 97657-92-6
ImpurityLatrepirdine Impurity 1Cat. No. P-L026-002CAS 23224-24-0
ImpurityLatrepirdine Impurity 2Cat. No. P-L026-003CAS 1147893-81-9
ImpurityLatrepirdine N-OxideCat. No. P-L026-004CAS 1147893-84-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.